ProCE Banner Activity

Telomerase Inhibition With Imetelstat in Refractory Anemia (RARS/RARS-T)

Slideset Download
Conference Coverage
Promising early-phase results suggest potential benefit to telomerase inhibition in RARS/RARS-T.

Released: December 09, 2015

Expiration: December 07, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen